OTCMKTS:NXEN Nexien BioPharma (NXEN) Stock Price, News & Analysis → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free NXEN Stock Alerts $0.02 +0.00 (+1.13%) (As of 05/17/2024 12:09 PM ET) Add Compare Share Share Today's Range$0.0179▼$0.017950-Day Range$0.02▼$0.0352-Week Range$0.01▼$0.10Volume9,000 shsAverage Volume11,596 shsMarket Capitalization$1.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get Nexien BioPharma alerts: Email Address Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. About Nexien BioPharma Stock (OTCMKTS:NXEN)Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.Read More NXEN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXEN Stock News HeadlinesOctober 31, 2023 | finance.yahoo.comNexien BioPharma, Inc. (NXEN)See More Headlines Receive NXEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nexien BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/18/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:NXEN CUSIPN/A CIK1625288 Webwww.nexienbiopharma.com Phone(303) 495-7583FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-360,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-1,092.92% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares67,470,000Free Float46,826,000Market Cap$1.21 million OptionableNot Optionable Beta1.64 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Richard S. Greenberg (Age 75)Founder, CEO, Executive VP & Chairman Mr. Evan L. Wasoff CPA (Age 76)Chief Financial Officer Mr. Robert I. Goldfarb J.D. (Age 68)Esq., Chief Operating Officer Comp: $55kKey CompetitorsNeuBase TherapeuticsNASDAQ:NBSEInspyr TherapeuticsOTCMKTS:NSPX180 Life SciencesNASDAQ:ATNFGRI BioNASDAQ:GRIBriaCell TherapeuticsOTCMKTS:BCTXFView All Competitors NXEN Stock Analysis - Frequently Asked Questions How have NXEN shares performed in 2024? Nexien BioPharma's stock was trading at $0.0259 at the beginning of the year. Since then, NXEN shares have decreased by 30.9% and is now trading at $0.0179. View the best growth stocks for 2024 here. Are investors shorting Nexien BioPharma? Nexien BioPharma saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average trading volume of 22,100 shares, the days-to-cover ratio is presently 1.3 days. View Nexien BioPharma's Short Interest. How do I buy shares of Nexien BioPharma? Shares of NXEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NXEN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexien BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.